Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3244 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

3SBio names new COO

Since joining 3SBio in June 2007, Dr Chen has been responsible for developing long-range growth strategies and pursuing strategic business opportunities and external alliances with biotechnology and pharmaceutical

TMD launches PhosphoGuard kit

Targeted Molecular Diagnostics (TMD) has formulated a proprietary solution of broad-spectrum phosphatase inhibitors in the PhosphoGuard kit which has been used in several Phase II and III oncology

CardioNet prices public offer at $18

In addition, Guidant Investment has granted to the underwriters a 30-day option to purchase up to an additional 675,000 shares of common stock to cover over-allotments, if any.

Merck Serono introduces Cyanokit in Japan

Cyanokit was approved by the Japanese Ministry of Health in November 2007, for the treatment of cyanide intoxication caused by hydrocyanic acid and its derivatives in both adults

MacroChem names new CFO

Mr Luci was formerly the CFO of Bioenvision prior to its successful merger transaction with Genzyme valued at $345 million, and has over 16 years of experience servicing

Sagent launches ciprofloxacin injection

Sagent’s ciprofloxacin injection will be available immediately in 200mg and 400mg premix bags. Ciprofloxacin injection, USP, is a synthetic broad spectrum antimicrobial agent and is the generic equivalent